59 related articles for article (PubMed ID: 24091038)
1. Quantitative morphological analysis of arrestin2 clustering upon G protein-coupled receptor stimulation by super-resolution microscopy.
Truan Z; Tarancón Díez L; Bönsch C; Malkusch S; Endesfelder U; Munteanu M; Hartley O; Heilemann M; Fürstenberg A
J Struct Biol; 2013 Nov; 184(2):329-34. PubMed ID: 24091038
[TBL] [Abstract][Full Text] [Related]
2. Coordinate-based co-localization-mediated analysis of arrestin clustering upon stimulation of the C-C chemokine receptor 5 with RANTES/CCL5 analogues.
Tarancón Díez L; Bönsch C; Malkusch S; Truan Z; Munteanu M; Heilemann M; Hartley O; Endesfelder U; Fürstenberg A
Histochem Cell Biol; 2014 Jul; 142(1):69-77. PubMed ID: 24623038
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screening of G protein-coupled receptor antagonists using a bioluminescence resonance energy transfer 1-based beta-arrestin2 recruitment assay.
Hamdan FF; Audet M; Garneau P; Pelletier J; Bouvier M
J Biomol Screen; 2005 Aug; 10(5):463-75. PubMed ID: 16093556
[TBL] [Abstract][Full Text] [Related]
4. Potent Anti-HIV Chemokine Analogs Direct Post-Endocytic Sorting of CCR5.
Bönsch C; Munteanu M; Rossitto-Borlat I; Fürstenberg A; Hartley O
PLoS One; 2015; 10(4):e0125396. PubMed ID: 25923671
[TBL] [Abstract][Full Text] [Related]
5. Arrestin Recruitment to C-C Chemokine Receptor 5: Potent C-C Chemokine Ligand 5 Analogs Reveal Differences in Dependence on Receptor Phosphorylation and Isoform-Specific Recruitment Bias.
Martins E; Brodier H; Rossitto-Borlat I; Ilgaz I; Villard M; Hartley O
Mol Pharmacol; 2020 Nov; 98(5):599-611. PubMed ID: 32943494
[TBL] [Abstract][Full Text] [Related]
6. Characterization of RANTES- and aminooxypentane-RANTES-triggered desensitization signals reveals differences in recruitment of the G protein-coupled receptor complex.
Vila-Coro AJ; Mellado M; Martín de Ana A; Martínez-A C; Rodríguez-Frade JM
J Immunol; 1999 Sep; 163(6):3037-44. PubMed ID: 10477567
[TBL] [Abstract][Full Text] [Related]
7. β-Arrestin recruitment and G protein signaling by the atypical human chemokine decoy receptor CCX-CKR.
Watts AO; Verkaar F; van der Lee MM; Timmerman CA; Kuijer M; van Offenbeek J; van Lith LH; Smit MJ; Leurs R; Zaman GJ; Vischer HF
J Biol Chem; 2013 Mar; 288(10):7169-81. PubMed ID: 23341447
[TBL] [Abstract][Full Text] [Related]
8. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
Andrews G; Jones C; Wreggett KA
Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of internalization and recycling of the chemokine receptor, CCR5.
Mueller A; Strange PG
Eur J Biochem; 2004 Jan; 271(2):243-52. PubMed ID: 14717692
[TBL] [Abstract][Full Text] [Related]
10. pH-independent endocytic cycling of the chemokine receptor CCR5.
Signoret N; Christophe T; Oppermann M; Marsh M
Traffic; 2004 Jul; 5(7):529-43. PubMed ID: 15180829
[TBL] [Abstract][Full Text] [Related]
11. Class B β-arrestin2-dependent CCR5 signalosome retention with natural antibodies to CCR5.
Venuti A; Pastori C; Pennisi R; Riva A; Sciortino MT; Lopalco L
Sci Rep; 2016 Dec; 6():39382. PubMed ID: 28008933
[TBL] [Abstract][Full Text] [Related]
12. Agonist-induced endocytosis of CC chemokine receptor 5 is clathrin dependent.
Signoret N; Hewlett L; Wavre S; Pelchen-Matthews A; Oppermann M; Marsh M
Mol Biol Cell; 2005 Feb; 16(2):902-17. PubMed ID: 15591129
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of the chemokine receptor, CCR5.
Mueller A; Mahmoud NG; Goedecke MC; McKeating JA; Strange PG
Br J Pharmacol; 2002 Feb; 135(4):1033-43. PubMed ID: 11861332
[TBL] [Abstract][Full Text] [Related]
14. Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication.
Ferain T; Hoveyda H; Ooms F; Schols D; Bernard J; Fraser G
J Pharmacol Exp Ther; 2011 Jun; 337(3):655-62. PubMed ID: 21389095
[TBL] [Abstract][Full Text] [Related]
15. Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5.
Leach K; Charlton SJ; Strange PG
Biochem Pharmacol; 2007 Sep; 74(6):881-90. PubMed ID: 17645873
[TBL] [Abstract][Full Text] [Related]
16. The functional antagonist Met-RANTES: a modified agonist that induces differential CCR5 trafficking.
Kiss DL; Longden J; Fechner GA; Avery VM
Cell Mol Biol Lett; 2009; 14(4):537-47. PubMed ID: 19448977
[TBL] [Abstract][Full Text] [Related]
17. Molecular anatomy of CCR5 engagement by physiologic and viral chemokines and HIV-1 envelope glycoproteins: differences in primary structural requirements for RANTES, MIP-1 alpha, and vMIP-II Binding.
Navenot JM; Wang ZX; Trent JO; Murray JL; Hu QX; DeLeeuw L; Moore PS; Chang Y; Peiper SC
J Mol Biol; 2001 Nov; 313(5):1181-93. PubMed ID: 11700073
[TBL] [Abstract][Full Text] [Related]
18. C5a-stimulated recruitment of beta-arrestin2 to the nonsignaling 7-transmembrane decoy receptor C5L2.
Van Lith LH; Oosterom J; Van Elsas A; Zaman GJ
J Biomol Screen; 2009 Oct; 14(9):1067-75. PubMed ID: 19641221
[TBL] [Abstract][Full Text] [Related]
19. CC chemokine receptor 5 (CCR5) desensitization: cycling receptors accumulate in the trans-Golgi network.
Escola JM; Kuenzi G; Gaertner H; Foti M; Hartley O
J Biol Chem; 2010 Dec; 285(53):41772-80. PubMed ID: 21041313
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of agonist-dependent parathyroid hormone receptor trafficking in whole cells using a functional green fluorescent protein conjugate.
Conway BR; Minor LK; Xu JZ; D'Andrea MR; Ghosh RN; Demarest KT
J Cell Physiol; 2001 Dec; 189(3):341-55. PubMed ID: 11748592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
